|
CME Outfitters Announces Live CE Series: "Depression with Atypical Features Part II: Evidence for New Treatment Options in a Clinical Case Series" Premieres Wed, Nov. 1 CME Outfitters announces an upcoming live and interactive educational audioconference series titled "Depression with Atypical Features Part II: Evidence for New Treatment Options in a Clinical Case Series." Offered as a series of 15 live and interactive audioconferences premiering Wednesday, November 1, 2006, from 5:15-6:15 p.m. ET, the series will focus on providing case-based educational information and clinical context regarding the appropriate treatment options for patients with depression with atypical features. Rockville, MD (PRWEB) September 26, 2006 -- CME Outfitters, LLC, nationally accredited provider of multidisciplinary medical education programming and related healthcare communications services, is pleased to announce an upcoming live and interactive evidence-based educational audioconference series titled "Depression with Atypical Features Part II: Evidence for New Treatment Options in a Clinical Case Series."
Offered as a series of 15 live and interactive audioconferences premiering Wednesday, November 1, 2006, from 5:15-6:15 p.m. ET, the series will focus on providing case-based educational information and clinical context regarding the appropriate treatment options for patients with depression with atypical features. This CE activity will also be available as an archived telephone audioconference shortly after the audioconference premiere, and available as an archived webcast, podcast, and multimedia CD-ROM in December 2006.
There is no fee for participation in this activity, or to obtain a CE certificate; however, registration is required. Three forms of registration are accepted: Online: Visit the activity details page at http://www.cmeoutfitters.com/cmea.asp?ID=215 Phone: Call 877.CME.PROS (877.263.7767) Fax: Visit the activity details page at http://www.cmeoutfitters.com/cmea.asp?ID=215, print and complete the activity details form, and fax to 240.243.1033
Statement of Need Major depressive disorder affects an estimated 23 million adult Americans each year and is associated with significant morbidity and mortality, impaired social and physical functioning, and increased risk for suicide. Over the years, a wide range of treatments have become available for depression, including monoamine oxidase inhibitors, tricyclic antidepressants, selective serotonin reuptake inhibitors, bupropion, venlafaxine, and cognitive behavioral therapy. Although a substantial proportion of patients do not initially respond to treatment, recent evidence from the STAR*D trials indicates that augmentation or switching to a different antidepressant can improve remission rates. However, many antidepressants have contraindications or require dietary restrictions that could interfere with medication compliance. Emerging data demonstrate that newer delivery systems may provide improved antidepressant benefit, particularly in patients reporting depression with atypical features. In this second of a two-part interactive and case-based CME Outfitters educational activity, the experts will use case studies to illustrate challenges facing clinicians in the treatment of depression and will explore novel treatment strategies in the management of depression. Part one of this series, "Depression with Atypical Features Part I: Recognition, Diagnosis, and Management," premiered in June 2006 and focused on evidence-based educational information and clinical context regarding the efficacy of medications used in the treatment of depression with atypical features. Archived versions of part one are available online at http://www.cmeoutfitters.com/cmea.asp?ID=210.
Faculty Charles B. Nemeroff, MD, PhD Reunette W. Harris Professor and Chairman Department of Psychiatry and Behavioral Sciences Emory University School of Medicine Atlanta, GA
Michael E. Thase, MD Professor of Psychiatry Department of Psychiatry University of Pittsburgh Medical Center Pittsburgh, PA
Learning Objectives At the end of this CE activity, participants should be able to: - Compare and contrast existing and novel treatment options for the treatment of depression with atypical features. - Identify potential drug-drug interactions and the impact on treatment selection for depression with atypical features. - Develop treatment strategies that utilize novel pharmacological approaches to achieve optimal outcomes in patients diagnosed with depression with atypical features.
Target Audience Physicians, physician assistants, nurse practitioners, nurses, psychologists, social workers, certified case managers, pharmacists, and other healthcare professionals with an interest in mental health.
Commercial Support CME Outfitters, LLC, gratefully acknowledges an educational grant from Bristol-Myers Squibb Company in support of this CE activity.
Credit Information CME Credit (Physicians CME Outfitters, LLC, is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. CME Outfitters, LLC, designates this educational activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity. Note to Physician Assistants: AAPA accepts Category I credit from AOACCME, Prescribed credit from AAFP, and AMA Category I CME credit for the PRA from organizations accredited by ACCME.
CNE Credit (Nurses) This Educational Activity is presented by CME Outfitters, LLC, which has been approved as a provider of continuing education by the New York State Nurses Association, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation. It has been assigned code 5UYSJZ-PRV-04103. 1.2 contact hours (Pharmacology)
CEP Credit (Psychologists) CME Outfitters is approved by the American Psychological Association to sponsor continuing education for psychologists. CME Outfitters maintains responsibility for this program and its content. (1.0 CE credits)
NASW Credit (Social Workers) This program was approved by the National Association of Social Workers (provider #886407722) for 1 continuing education contact hour.
CCMC Credit (Certified Case Managers) This program has been approved for 1 hour by the Commission for Case Manager Certification (CCMC).
CPE Credit (Pharmacists) CME Outfitters, LLC, is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. 1.0 contact hours (0.1 CEUs) Universal Program Number: 376-999-06-019-L01 (live interactive session) 376-999-06-019-H01 (recorded activities)
To receive credit, participants must review all activity materials in their entirety, score 70% or above on a post-test, and fully complete and return both the credit request form and activity evaluation. A certificate or statement of credit will be mailed within 4-6 weeks to all who successfully complete these requirements.
About CME Outfitters CME Outfitters is a full service healthcare communications agency providing continuing education content development, production, marketing, accreditation, and project management services to the healthcare industry. Among its many collaborative ventures, CME Outfitters has played a primary role in the production, certification, marketing, and logistical support for the popular psychCME series of educational activities. For more information on CME Outfitters, including a complete calendar of its free award-winning educational activities, please visit http://www.cmeoutfitters.com, or call 877.CME.PROS (877.263.7767).
To view all of CME Outfitters' recent press releases, visit http://www.cmeoutfitters.com and click on "CME Outfitters in the News" or visit http://www.prweb.com and search for "CME Outfitters."
CME Outfitters publishes a weekly e-newsletter, which is a convenient way to stay informed of all CME Outfitters news and information. To subscribe, visit http://www.cmeoutfitters.com and click on "Register for Updates."
Contact: Jessica Primanzon CME Outfitters, LLC 240.243.1308 direct 240.243.1033 fax
###
|
© Copyright 1997-2008, Vocus PRW Holdings, LLC. |